Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lis Ribeiro-Müller

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinics in Dermatology|February 25, 2014
Prophylactic papillomavirus vaccinesLis Ribeiro-Müller, Martin Müller
Plos One|October 15, 2013
High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomavirusesPeter Sehr, Ivonne Rubio, Hanna Seitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 15, 2015
Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 VaccineHanna Seitz, Lis Ribeiro-Müller, Elena Canali, et al.
Vaccine|March 26, 2014
A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomavirusesHanna Seitz, Elena Canali, Lis Ribeiro-Müller, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinics in Dermatology|February 25, 2014
Prophylactic papillomavirus vaccinesLis Ribeiro-Müller, Martin Müller
Plos One|October 15, 2013
High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomavirusesPeter Sehr, Ivonne Rubio, Hanna Seitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 15, 2015
Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 VaccineHanna Seitz, Lis Ribeiro-Müller, Elena Canali, et al.
Vaccine|March 26, 2014
A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomavirusesHanna Seitz, Elena Canali, Lis Ribeiro-Müller, et al.
Pageof 1